YODA

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of central nervous system disorders or diseases, namely, neurological illnesses, psychiatric illnesses, and neurodegenerative diseases; pharmaceutical preparations for the treatment of psychiatric, emotional and behavioral disorders, namely, depression, bi-polar disorder, anxiety, panic disorder, schizophrenia, schizoaffective disorder, positive syndrome, negative syndrome, mood and cognitive related symptoms of psychiatric illnesses, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD); pharmaceutical preparations for the treatment of brain injuries, namely, traumatic brain injury (TBI), brain ischemia, post-stroke recovery, post-hemorrhage recovery, reversible cerebral vasoconstriction syndrome, spinal cord injury, convulsion, epileptic seizures; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Parkinson's disease (PD), Alzheimer's disease (AD), dementia, mild cognitive impairment (MCI), Huntington's disease (HD); pharmaceutical preparations for the treatment of loss of memory, cognition, or loss of neuronal functions associated with neurodegenerative diseases or aging; pharmaceutical preparations for the treatment of neurological diseases, namely, ataxia, sporadic or hereditary ataxias, cerebellar ataxia, parkinsonism ataxia, multiple system atrophy (MSA), Friedreich's ataxia, spinocerebellar ataxia, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), muscular dystrophy; pharmaceutical preparations for the treatment of neurodevelopmental disorders, namely, Tourette syndrome (TS), autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), developmental language disorder (DLD), Fragile-X syndrome (FXS), Rett syndrome, cerebral palsy; pharmaceutical preparations for the treatment of pain, namely, neuropathic pain; Pharmaceutical preparations for the treatment of inflammatory disorder or diseases, namely, inflammasome-related diseases, immunological diseases; pharmaceutical preparations for the treatment of auto-inflammatory diseases or auto-immune diseases, namely, multiple sclerosis (MS), systemic sclerosis (SSc), rheumatoid arthritis (RA), lupus, gout, inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis, chronic inflammation, auto-inflammatory fever syndromes, cryopyrin-associated periodic syndromes (CAPS); pharmaceutical preparations for the treatment of liver-related inflammatory diseases, namely, chronic liver disease, non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis; pharmaceutical preparations for the treatment of kidney-related inflammatory diseases, namely, chronic kidney disease (CKD), hypertensive nephropathy, lupus nephritis, Type I diabetes, Type II diabetes, hemodialysis related inflammation; pharmaceutical preparations for the treatment of cardiovascular-related inflammatory diseases, namely, chronic heart disease (CHD), peripheral artery disease (PAD), hypertension, atherosclerosis, acute heart failure, systemic lupus erythematosus (SLE); pharmaceutical preparations for the treatment of neuroinflammation-related diseases, namely, Parkinson's disease (PD), Alzheimer's disease (AD), dementia, mild cognitive impairment (MCI), Huntington's disease (HD), traumatic brain injury (TBI), brain ischemia, ataxia, multiple system atrophy (MSA), Friedreich's ataxia, spinocerebellar ataxia, amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), multiple sclerosis (MS), muscular dystrophy, Tourette syndrome (TS), autism spectrum disorder (ASD), Fragile-X syndrome (FXS), Rett syndrome, cerebral palsy; pharmaceutical preparations for the treatment of age-related inflammatory degenerative diseases, namely, Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), parkinsonism-dementia complex of Guam, atherosclerosis, osteoarthritis, neuronal cell death; Pharmaceutical drugs, namely, anti-inflammatory agents, antioxidants, antidepressants, antipsychotics, anti-Parkinson agents, central nervous system agents, stimulants, inhibitors, modulators, benzodiazepines, serotoninergic agents, dopaminergic agents, glutaminergic agents, analgesics, neuromuscular agents, and psychotherapeutic agents